
Landon Trost, MD, discusses patient-reported outcomes from a study comparing CCH treatment vs surgery for Peyronie's disease.
Landon Trost, MD, discusses patient-reported outcomes from a study comparing CCH treatment vs surgery for Peyronie's disease.
“It definitely makes it easier for providers [to counsel patients]," says Landon Trost, MD.
"This now clarifies and substantiates the fact that there are not increased risks from a cardiovascular standpoint with [testosterone] therapy, at least at the doses studied," says Landon Trost, MD.
"There's something coming out of Canada. It's a kiwi extract, which is a natural collagenase that comes from kiwi," says Landon Trost, MD.
"It's often a balancing act of truly kind of pinning down people on what exactly they want to treat," says Landon Trost, MD.
These videos depict key steps of office-based approaches to hydrocelectomy and vasectomy reversal.
Published: December 11th 2017 | Updated: